Digest Network Come funziona
Network
/
Società
Jo
Non verificato

Johnson & Johnson

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàWeb e Social Network

88 comunicati stampa

Guarda tutti i comunicati
11/06/2026
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
08/06/2026
Mercato azionario
Oncologia
Attrezzature medico-sanitarie
Salute
Sanità
Farmaceutica
Biotecnologia
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
27/05/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
21/05/2026
Johnson & Johnson Advances Creation of Global Intelligent OR Network in collaboration with Department of Health - Abu Dhabi
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
12/05/2026
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
11/05/2026
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
05/05/2026
Eventi
Industria
Igiene alimentare
Tecnica
Farmaceutica
Medicina - Varie
Sanità
Attrezzature medico-sanitarie
Tecnologie Varie
Biotecnologia
Scienza
Salute
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
30/04/2026
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
27/04/2026
Web e Social Network
Eventi
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
22/04/2026
Johnson & Johnson Announces CE Mark Approval for the New ETHICON™ 4000 Stapler
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0